Aspergillus Galactomannan Antigen in the Cerebrospinal Fluid of Bone Marrow Transplant Recipients with Probable Cerebral Aspergillosis
AUTOR(ES)
Viscoli, Claudio
FONTE
American Society for Microbiology
RESUMO
The Aspergillus galactomannan test was performed on cerebrospinal fluid and serum samples from 5 patients with probable cerebral aspergillosis and from 16 control patients. Cerebrospinal fluid galactomannan levels were significantly higher in aspergillosis patients, and most galactomannan was produced intrathecally. Comparison of serum galactomannan values in pulmonary and cerebral aspergillosis patients showed significant overlapping. Detection of Aspergillus galactomannan in cerebrospinal fluid may be diagnostic of cerebral aspergillosis.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=140329Documentos Relacionados
- Efficacy of Galactomannan Antigen in the Platelia Aspergillus Enzyme Immunoassay for Diagnosis of Invasive Aspergillosis in Liver Transplant Recipients
- Reactivation of polyomavirus in bone marrow transplant recipients.
- Investigation of potential interaction of ciprofloxacin with cyclosporine in bone marrow transplant recipients.
- Coaggregation of oral Candida isolates with bacteria from bone marrow transplant recipients.
- Molecular Methods for Cytomegalovirus Surveillance in Bone Marrow Transplant Recipients
